Next-Generation Sequencing (NGS)-based Measurable Residual Disease (MRD) monitoring in Acute Myeloid Leukemia with FLT3 Internal Tandem Duplication (FLT3-ITD+ AML) treated with additional midostaurin

被引：0

作者：

Herzig, J. K. ^{[1
]}

Ruecker, F. G. ^{[1
]}

Schmalbrock, L. K. ^{[1
]}

Skambraks, S. ^{[1
]}

Luck, T. J. ^{[1
,2
]}

Weber, D. ^{[1
]}

Kapp-Schwoerer, S. ^{[1
]}

Corbacioglu, A. ^{[1
]}

Gaidzik, V., I ^{[1
]}

Panina, E. ^{[1
]}

Jahn, N. ^{[1
]}

Schrade, A. ^{[1
]}

Theis, F. ^{[1
]}

Cocciardi, S. ^{[1
]}

Fiedler, W. ^{[3
]}

Salih, H. R. ^{[4
]}

Wulf, G. ^{[5
]}

Salwender, H. ^{[6
]}

Schroeder, T. ^{[7
]}

Gotze, K. S. ^{[8
]}

Kindler, T. ^{[9
]}

Luebbert, M. ^{[10
,11
]}

Schlenk, R. F. ^{[12
,13
,14
]}

Thol, F. ^{[15
]}

Heuser, M. ^{[15
]}

Ganser, A. ^{[15
]}

Doehner, H. ^{[1
,15
]}

Bullinger, L. ^{[2
]}

Doehner, K. ^{[1
]}

机构：

[1] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany

[2] Charite, Dept Hematol Oncol & Tumor Immunol, Berlin, Germany

[3] Hubertus Wald Univ, Univ Med Ctr Hamburg Eppendorf, Canc Ctr, Hamburg, Germany

[4] Eberhard Karls Univ Tubingen, Dept Hematol & Oncol, Tubingen, Germany

[5] Univ Hosp Gottingen, Dept Hematol & Oncol, Gottingen, Germany

[6] Asklepios Tumorzentrum Hamburg, AK Altona & AK St Georg, Hamburg, Germany

[7] Univ Hosp Dusseldorf, Dept Hematol Oncol & Clin Immunol, Dusseldorf, Germany

[8] TUM, Dept Med 3, Klinikum Rechts Isar, Munich, Germany

[9] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Hematol Oncol & Pneumol, Mainz, Germany

[10] Univ Freiburg, Dept Hematol Oncol & StemCell Transplantat, Fac Med, Freiburg, Germany

[11] Univ Freiburg, Dept Hematol Oncol & StemCell Transplantat, Med Ctr, Freiburg, Germany

[12] Heidelberg Univ Hosp, Dept Internal Med 5, Heidelberg, Germany

[13] German Canc Res Ctr, Heidelberg, Germany

[14] Heidelberg Univ Hosp, Natl Ctr Tumor Dis, NCT Trial Ctr, Heidelberg, Germany

[15] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2021年 / 44卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

V164

引用

页码：93 / 94

页数：2

共 50 条

[1] Next-Generation Sequencing (NGS)-Based Measurable Residual Disease (MRD) Monitoring in Acute Myeloid Leukemia with FLT3 Internal Tandem Duplication (FLT3-ITD+ AML) Treated with Additional Midostaurin
Herzig, Julia K.
Rucker, Frank G.
Schmalbrock, Laura K.
Blatte, Tamara J.
Weber, Daniela
Skambraks, Sabrina
Kapp-Schwoerer, Silke
Corbacioglu, Andrea
Gaidzik, Verena I.
Paschka, Peter
Panina, Ekaterina
Jahn, Nikolaus
Schrade, Anika
Theis, Frauke
Cocciardi, Sibylle
Fiedler, Walter
Salih, Helmut R.
Wulf, Gerald
Salwender, Hans
Schroeder, Thomas
Gotze, Katharina S.
Kindler, Thomas
Luebbert, Michael
Schlenk, Richard F.
Thol, Felicitas
Heuser, Michael
Ganser, Arnold
Dohner, Hartmut
Bullinger, Lars
Dohner, Konstanze
BLOOD, 2020, 136
[2] Quantification of the FLT3 internal tandem duplication is a reliable marker for monitoring measurable residual disease in acute myeloid leukemia with FLT3-ITD mutations
Wang, Meng-Miao
Huang, Si-Man
Huang, Yuan-Hong
Zhang, Jian
Li, Hui-Ying
Ge, Shuai-Shuai
Wan, Chao-Ling
Wang, Miao
Liu, Hai-Hui
Cao, Han-Yu
Wang, Zi-Hao
Tan, Kai-Wen
Pang, Hong-Feng
Lyu, Xiao-Yu
Liu, Song-Bai
Dai, Hai-Ping
Xue, Sheng-Li
Qiu, Qiao-Cheng
BONE MARROW TRANSPLANTATION, 2024, : 412 - 414
[3] Next-generation sequencing of FLT3 internal tandem duplications for minimal residual disease monitoring in acute myeloid leukemia
Bibault, Jean-Emmanuel
Figeac, Martin
Helevaut, Nathalie
Rodriguez, Celine
Quief, Sabine
Sebda, Sheherazade
Renneville, Aline
Nibourel, Olivier
Rousselot, Philippe
Gruson, Berengere
Dombret, Herve
Castaigne, Sylvie
Preudhomme, Claude
ONCOTARGET, 2015, 6 (26) : 22812 - 22821
[4] FLT3-ITD Measurable Residual Disease Monitoring in Acute Myeloid Leukemia Using Next-Generation Sequencing
Lee, Jong-Mi
Park, Silvia
Hwang, Insik
Kang, Dain
Cho, Byung Sik
Kim, Hee-Je
Ahn, Ari
Kim, Myungshin
Kim, Yonggoo
CANCERS, 2022, 14 (24)
[5] Next-Generation Sequencing of FLT3/ITD for Minimal Residual Disease Monitoring in Leukemia Patients
Xie, Z.
Carson, A. R.
McClain, V.
Zheng, S.
Huang, W.
Miller, J. E.
Levis, M.
Stenzel, T.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2016, 18 (06): : 967 - 967
[6] FNIH MRD in AML Biomarkers Consortium: Evaluation of Methods for Detection of FLT3 Internal Tandem Duplication Measurable Residual Disease in Acute Myeloid Leukemia
Dillon, L.
Beppu, L.
Gui, G.
Al-Ali, R.
Diemer, J.
Craft, J.
Higgins, J.
Holman, M.
D'Angelo, J.
Jacobsen, A.
Amido, M.
Huang, Y.
Miller, J.
Zhang, H.
Mitchell, S.
Ding, B.
Zheng, L.
Kaznadzey, D.
Wei, E.
Lindsley, R. C.
Radich, J.
Hourigan, C.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (11): : S42 - S42
[7] Development of a novel next-generation sequencing (NGS)-based assay for measurable residual disease (MRD) in FLT3-ITD acute myeloid leukemia (AML) and its potential clinical application in patients
Shi, Wenge
Laing, Christian
Ding, Wei
Mycoco, Marc
Lameh, Jelveh
Pollner, Reinhold
CANCER RESEARCH, 2019, 79 (13)
[8] Hematopoietic transplantation for acute myeloid leukemia with internal tandem duplication of FLT3 gene (FLT3/ITD)
Brunet, Salut
Martino, Rodrigo
Sierra, Jorge
CURRENT OPINION IN ONCOLOGY, 2013, 25 (02) : 195 - 204
[9] Development of a Novel Next-Generation Sequencing (NGS)-Based Assay for Measurable Residual Disease (MRD) in FLT3-ITD AML and Its Potential Clinical Application in Patients Treated with Chemotherapy Plus FLT3 Inhibitors
Levis, Mark J.
Shi, Wenge
Chang, Ken C. N.
Laing, Christian
Berisha, Flora
Adams, Emily
Gocke, Christopher D.
Ding, Wei
Nakamaru, Kenji
Lameh, Jelveh
Pollner, Reinhold
Kobayashi, Ken
BLOOD, 2018, 132
[10] Minimal residual disease monitoring based on FLT3 internal tandem duplication in adult acute myeloid leukemia
Abdelhamid, Emna
Preudhomme, Claude
Helevaut, Nathalie
Nibourel, Olivier
Gardin, Claude
Rousselot, Philippe
Castaigne, Sylvie
Gruson, Berengere
Berthon, Celine
Soua, Zohra
Renneville, Aline
LEUKEMIA RESEARCH, 2012, 36 (03) : 316 - 323

← 1 2 3 4 5 →